Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0002065881-25-000003
Filing Date
2025-05-07
Accepted
2025-05-07 19:27:44
Documents
5
Period of Report
2025-05-06

Document Format Files

Seq Description Document Type Size
1 FORM 3 wk-form3_1746660457.html 3  
1 FORM 3 wk-form3_1746660457.xml 3 8581
2 EX-24 poaforlathavairavan04172.htm EX-24 4866
3 poaforlathavairavan04172001.jpg GRAPHIC 261305
4 poaforlathavairavan04172002.jpg GRAPHIC 37894
5 poaforlathavairavan04172003.jpg GRAPHIC 33810
  Complete submission text file 0002065881-25-000003.txt   473847
Mailing Address 3027 TOWNSGATE ROAD SUITE 300 WESTLAKE VILLAGE CA 91361
Business Address 3027 TOWNSGATE ROAD SUITE 300 WESTLAKE VILLAGE CA 91361 805-418-5006
Arcutis Biotherapeutics, Inc. (Issuer) CIK: 0001787306 (see all company filings)

EIN.: 812974255 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 3027 TOWNSGATE ROAD SUITE 300 WESTLAKE VILLAGE CA 91361
Business Address
Vairavan Latha (Reporting) CIK: 0002065881 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39186 | Film No.: 25923327